[3] The next tranche will also deal with legislating for the supplementary route in relation to the claims of the infected and affected communities, depending on their circumstances.

[4][5] The core route provides for set tariffs with predefined severity levels in relation to infection with Hepatitis B and Hepatitis C.[6] This route offers the option of receiving compensation as an overall lump sum, or as monthly payments, with further options as to the frequency of the payments over set periods of either 5, 10 or 25 years.

[13] For the IBCA to process an estate claim, the personal representative must provide documented evidence that under the law amounts to sufficient proof in the form of the following:[3] Sadly much of the compensation will be awarded in respect of people who have already died because of their infection.

[23] It is intended to afford an element of compensation for the distress suffered as a result of interference with the personal autonomy and private life of the infected.

[29] The UK Haemophilia Society cautiously welcomed the regulations but expressed concern that the compensation payment levels did not fully reflect the true impact of the financial loss and injury suffered by certain victims.

In their Second Report, published 5 September 2024, they draw instrument 2024/872 to the special attention of the House due to the explanatory memorandum being "of poor quality, using overly technical language and lacking basic information about the policy".

[30] The SLSC focused on five aspects all lacking further detail:[30] The committee went as far as to express concern over whether the Cabinet Office was "withholding information on the impact and cost of the Regulations".